Wed, December 11, 2024
Tue, December 10, 2024

New AI cracks complex engineering problems faster than supercomputers

The article from ScienceDaily discusses a study published in the journal *Nature Communications* that explores the potential of using a common cold virus, specifically a genetically modified adenovirus, to treat chronic pain. Researchers from the University of California, San Diego, found that this virus could be engineered to deliver a gene that produces a pain-relieving protein directly to the nervous system. The study demonstrated that when this modified virus was injected into mice, it significantly reduced pain sensitivity without the side effects commonly associated with traditional pain medications like opioids. This approach could offer a new, long-lasting treatment for chronic pain conditions, potentially reducing the reliance on addictive painkillers. The findings suggest a promising future for gene therapy in pain management, although further research is needed to ensure safety and efficacy in humans.

Read the Full Science Daily Article at:
[ https://www.sciencedaily.com/releases/2024/12/241209122936.htm ]